Latest News

PDC Therapeutics Announces Poster Presentation at the ESMO TAT 2023 Congress

PDC Therapeutics, a nanomedicines biotech company developing targeted Polymer Drug Conjugates that are aiming to provide cancer patients with an optimal therapeutic index, announced the acceptance of a poster presentation at the European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) 2023 Congress on 6-8 March in Paris – France, being known as “The Home of Phase I in Oncology”. […]

Read More